Clinical Trial Update: Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating rifaximin combined with a thiopurine to prevent postoperative recurrence in Crohn's disease. The study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• Azathioprine (azathioprine)
• XIFAXAN (rifaximin)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn Disease | Phase 3 | Status: UNKNOWN